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Approaches to overcome flow cytometry
limitations in the analysis of cells from
veterinary relevant species
Julia Hunka1,2, John T. Riley1 and Gudrun F. Debes1*

Abstract
Background: Flow cytometry is a powerful tool for the multiparameter analysis of leukocyte subsets on the single
cell level. Recent advances have greatly increased the number of fluorochrome-labeled antibodies in flow
cytometry. In particular, an increase in available fluorochromes with distinct excitation and emission spectra
combined with novel multicolor flow cytometers with several lasers have enhanced the generation of
multidimensional expression data for leukocytes and other cell types. However, these advances have mainly
benefited the analysis of human or mouse cell samples given the lack of reagents for most animal species. The flow
cytometric analysis of important veterinary, agricultural, wildlife, and other animal species is still hampered by
several technical limitations, even though animal species other than the mouse can serve as more accurate models
of specific human physiology and diseases.
Results: Here we present time-tested approaches that our laboratory regularly uses in the multiparameter flow
cytometric analysis of ovine leukocytes. The discussed approaches will be applicable to the analysis of cells from
most animal species and include direct modification of antibodies by covalent conjugation or Fc-directed labeling
(Zenon™ technology), labeled secondary antibodies and other second step reagents, labeled receptor ligands, and
antibodies with species cross-reactivity.
Conclusions: Using refined technical approaches, the number of parameters analyzed by flow cytometry per cell
sample can be greatly increased, enabling multidimensional analysis of rare samples and giving critical insight into
veterinary and other less commonly analyzed species. By maximizing information from each cell sample, multicolor
flow cytometry can reduce the required number of animals used in a study.
Keywords: Flow cytometry, Multiparameter, Veterinary species

Background
Fluorescence-activated cell sorting (FACS) and flow cytometry have been essential immunological tools since
the invention of FACS in the late 1960s [1–3], as they
enable identification, characterization, and isolation of
defined leukocyte subsets [4, 5]. Flow cytometry employs
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fluorochrome-labeled antibodies that detect cell surface
or intracellular antigens [6, 7], a method that was first
developed for characterization of cells and tissues by microscopy [8]. Recent advances in the development of
novel fluorochromes and instrumentation (i.e. flow cytometry analyzers and sorters) allow for the theoretical
analysis of up to 50 parameters in a single staining panel
[9], and a 28-color panel has recently been demonstrated
[10]. Polychromatic experiments enable the simultaneous measurement of a larger number of cell surface
and intracellular markers, thereby facilitating the analysis
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of infrequent cell subsets or limited cell samples [5, 11–
13]. Therefore, many institutions have acquired high
capacity flow cytometers, and the analysis of > 10 fluorochromes has become routine in the study of human and
mouse cells.
The house mouse (Mus musculus) is the most frequently used species in biomedical research and, as a
consequence, a large spectrum of reagents and genetic
models are available [14, 15].. However, animal species
other than the house mouse may represent more suitable models of specific human physiology, disease or
anatomy, and can also enable studies of comparative
medicine and/or of zoonotic pathogens in their natural
hosts [14, 16, 17]. An example is the guinea pig, which
has been a model for human infectious diseases for 200
years, and enabled disease research and vaccine development in tuberculosis [18, 19]. More recent examples for
the use of non-mouse species in biomedical research
include pigs and sheep in orthopedics and Alzheimer’s
disease [20–22] and dogs in oncology [23].
Flow cytometry is a key method in immunological
studies [24] encompassing biomedical, veterinary, agricultural, and wildlife research, but the method is also
routinely employed in veterinary clinical laboratories
[25, 26]. Unfortunately, we face many limitations in the
analysis of non-mouse animal samples, including lower
availability of commercially or otherwise available antibodies to cell antigens and reduced options for fluorochrome labels by commercial antibody suppliers. It is
also not uncommon to receive limited amounts of hybridoma supernatant rather than purified antibody. In
addition, antibodies for non-standard species tend to be
more expensive. Due to this absolute and relative lack of
reagents, the design of state-of-the-art multicolor flow
cytometry staining panels is much more difficult than it
is for mouse or human cell samples.
Our laboratory studies lymphocyte recirculation using
lymph vessel cannulation in sheep, which was pioneered by
Bede Morris [27, 28]. Due to a number of limitations, afferent lymph vessels cannot be readily cannulated in mice or
humans, and lymph vessel cannulation in sheep allows for
the analysis of lymphocytes during their physiological
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recirculation through tissues [29–31]. Here we present
technical approaches that are commonly employed by our
laboratory to increase the number of parameters analyzed
by flow cytometry per cell sample from sheep [32–36]. The
discussed approaches are compatible with the analysis of
cells from most other animal species and include direct
modification of antibodies by covalent conjugation or Fcdirected labeling (Zenon™ labeling kits), labeled secondary
antibodies and other second step reagents, labeled receptor
ligands and species cross-reactivity. Detailed guidelines for
the use of flow cytometry, including general protocols, are
extensively discussed elsewhere [11, 24].

Results
Selection of fluorochromes

When designing multicolor staining panels for flow cytometry, one is limited to the use of fluorochromes compatible
with available flow cytometers. Therefore, the technical
specificities of the available instrumentation determine the
fluorochromes in a staining panel. For the panels presented
in this paper we used the BD LSR Fortessa™ cell analyzer.
Our machine has 5 lasers, UV (355 nm), violet (405 nm),
blue (488 nm), yellow/green (561 nm), and red (640 nm),
and can simultaneously detect up to 18 colors plus forward- (FSC) and side scatter (SSC) properties (Fig. 1). Figure 1 depicts the specific laser and filter set-up of our flow
cytometer, its theoretically available colors, as well as examples for fluorochromes commonly used in our laboratory. As advised [37], we aim to choose fluorochromes
with minimal spectral overlap, and online resources such
as the Spectrum Viewer from BD, Fluorescence Spectra
Viewer from Thermo Fisher Scientific, or the BioLegend
Spectra Analyzer help with assessing the degree of spectral
overlap and potential spillover. The simultaneous use of
fluorochromes with extensive spectral overlap is more
feasible with appropriate compensation, carefully titrated
antibodies, and when the antibodies recognize distinct cell
populations, e.g. B cells vs. T cells; the approach is less
suitable for co-expression studies [24, 38]. However, each
specific staining panel will need to be tested and optimized on available instrumentation. More details on

Fig. 1 Flow cytometry laser and fluorochrome chart used for our studies. The BD LSR Fortessa™ used in this study is depicted with our laser and
corresponding filter set-up, as well as fluorochrome examples commonly used in our laboratory. Abbreviations: AF™, Alexa Fluor™; APC,
allophycocyanin; BUV, Brilliant UltraViolet™; BV, Brilliant Violet™; CF, Cyanine-based fluorescent dye; Cy, Cyanine; DAPI, 4′,6-diamidino-2phenylindole; eF, eFluor; FITC: fluorescein isothiocyanate; LP, long pass; PE, R-phycoerythrin; PE-Cy5, phycoerythrin-cyanine5 conjugate; PE-Cy7,
phycoerythrin-cyanine7 conjugate; PerCP, peridinin chlorophyll-A protein
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optimal fluorochrome combinations and discussions on
appropriate compensation techniques are described elsewhere [12, 24, 37].
When designing staining panels, we select brighter fluorochromes for antibodies that bind rare antigens as advised
[37]. Companies such as BioLegend provide a relative
brightness index for fluorochromes but also warn that the
brightness can vary depending on the antibody, antigen, or
cell type, and that it is also influenced by instrumentation.
Consequently, titrating the antibody is always recommended. Examples of brighter fluorochromes that we used
in our panels of this paper include phycoerythrin (PE),
Alexa Fluor™ (AF™) 594, phycoerythrin-cyanine 7 (PE-Cy7),
allophycocyanin (APC), and Brilliant Violet™ 421 (BV421)
(Fig. 1). In an ideal scenario, monoclonal antibodies for
each cell antigen are available in all possible fluorochromes.
However, even for human antigens this is not the case and
is further from reality in veterinary species. Thus, initial
antibody staining panel design will depend on easily available and previously validated antibodies (“what is in the refrigerator”) and approaches to expand the panel.
Covalent labeling of antibodies and species-cross-reactive
antibodies

Antibody vendors have a variable supply, and antibodies for
veterinary species are generally available in a limited number of fluorochrome labels and are often unconjugated.
BioRad, for example, has a sound variety of anti-ovine and
other veterinary antibodies, most of which are only available purified or conjugated to fluorescein isothiocyanate
(FITC) or PE. A method to broaden the fluorochrome
range is to label purified antibodies by using a reactive labeling kit that covalently binds fluorochromes to reactive
protein groups, such as amines. In contrast to purified antibodies, non-purified antibodies (i.e. hybridoma supernatants, ascites fluid) cannot be labeled covalently without
also labeling other protein components in the fluid, but
they can be selectively labeled with the Zenon™ labeling
method (discussed below). Covalent labeling kits for variable amounts of antibody are available for numerous fluorochromes from commercial vendors, such as Invitrogen™
by Thermo Fisher Scientific, Novus Biologicals, Abcam, or
Biotium™. The labeling procedure follows simple protocols
provided by the manufacturer and takes less than 3 hours.
The newly labeled antibody is immediately ready for staining but should be titrated and validated prior to use in an
experiment. The reactive label works for all animal species
and IgG subclasses, and the covalently labeled antibody is
stable and can be stored for usage over several months. For
example, we labeled purified anti-ovine CD8 with a Pacific
Blue™ antibody labeling kit and included it in a multicolor
panel to detect CD8+ T cells among sheep blood lymphocytes (Fig. 2a). Within the same staining panel, lymphocytes
were additionally gated for γδ T cells (Population A), CD4
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T cells (C), B cells (D), and CD11c+ antigen presenting cells
(E) distinguished within the high side scatter granulocyte
population (Fig. 2a).
To broaden the antibody repertoire and fluorochrome
spectrum, many laboratories use antibodies that are
raised against antigens in one species but exhibit documented cross-reactivity for a different species. When
antibodies are produced for use in mice and humans,
they are more likely to be commercially available in a
larger variety of colors. In our example panel, we took
advantage of documented cross-reactivity of anti-human
α4- and β1-integrin and anti-bovine CD21 antibodies
with their corresponding sheep molecules [39, 40] and
analyzed all cell subsets (A-E) for these markers, as well
as CD62L (Fig. 2b).
Staining controls are particularly important for multiparameter analyses [37]. In a fluorescence minus one
(FMO) control all antibodies of the panel, except for
one, are included in their respective fluorochromes,
allowing assessment of spectral overlap into the “empty”
channel (Fig. 2c). Figure 2d depicts the individual fluorochromes and antibodies to antigens used in the staining
panel of Fig. 2 and lists the method by which the individual staining was achieved.
Zenon™ labeling kits

An additional approach to overcome limited fluorochrome availability for domesticated and other animal
species is the use of Zenon™ labeling kits (Invitrogen™,
Thermo Fisher Scientific) [33, 34, 41, 42]. The Zenon™
labeling technique uses fluorochrome-labeled Fab antibody fragments that recognize the IgG subclass (Fc portion) of its target antibody (Fig. 3). This noncovalent
conjunction enables the labeling of human, mouse and
rabbit antibodies, which can be purified antibodies, hybridoma culture supernatant, or ascites fluid [43]. Therefore, the Fab fragment of the Zenon™ kit has to
recognize the species (human, mouse or rabbit) and the
IgG subclass (IgG1, IgG2a or IgG2b) of the specific target
antibody. To label the target antibody, it is mixed with
the fluorochrome-labeled Fab fragments of the Zenon™
kit, and the mixture is incubated for 5 min (Fig. 3a).
Next, the Zenon™ blocking reagent is added to the mixture and incubated for another 5 min (Fig. 3b). The
Zenon™ blocking reagent is a nonspecific immunoglobulin mix from the same species as the target antibody and
will bind to excess fluorochrome-labeled Fab fragments
(Fig. 3b). Finally, together with other antibodies of the
staining panel, the Zenon™ mixture is added to the cell
sample for staining (Fig. 3c). After washing to remove
unbound nonspecific immunoglobulins, the cells are
ready to be analyzed by flow cytometry (Fig. 3e).
For the labeling of purified monoclonal antibodies, our laboratory follows the Zenon™ labeling protocol provided
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Fig. 2 Staining and gating strategy to identify leukocyte populations in ovine blood. Peripheral blood mononuclear cells were obtained by
density gradient centrifugation and (a) cells were gated on FSC-Height and FSC-Area to exclude doublets. Singlets were further gated on SSCArea and LIVE/DEAD™-dyelow cells to exclude dead cells. Viable cells were then gated for lymphocytes and granulocytes based on FSC and SSC
properties. Lymphocytes were gated for γδ T cells (a), CD8+ T cells (b), CD4+ T cells (c), and B cells (d). Granulocytes were gated for CD11c+
antigen presenting cells (E). (b) Each leukocyte subset (A-E) was analyzed for expression of α4- and β1-integrins (top row) and CD21 and CD62L
(bottom). (c) Fluorescence-minus-one controls (FMO) for fluorochromes used to stain α4- and β1-integrins, CD21, and L-selectin in (b) using the
total lymphocyte gate shown in Panel (a). (d) Table indicating the reagents and flow cytometer configuration used in this staining panel,
including the respective fluorochrome, as well as the methods employed to visualize each ovine cell surface marker. Reagents that were obtained
as covalently labeled reagents are marked as “directly conjugated”. (a and b) Numbers within dot plots represent percentages. Abbreviations: AF™,
Alexa Fluor™; Bio, biotin; BV, Brilliant Violet™; FITC, fluorescein isothiocyanate; LP, long pass; mAb, Monoclonal antibody; PE, R-phycoerythrin; PECy7, phycoerythrin-cyanine7 conjugate; PerCP-Cy5.5, peridinin chlorophyll-A protein-cyanine; SA, streptavidin

with the kit, which recommends the use of 1 μg of target
antibody, 5 μl of the Zenon™ labeling complex and 5 μl of
the Zenon™ block. For some very bright fluorochromes and
antibodies that recognize highly expressed cell surface antigens, such as anti-γδ TCR antibody labeled with Zenon™
AF™594 (Fig. 2), we only use 2.5 μl of the Zenon™ labeling
Fab fragment and 2.5 μl of the Zenon™ blocking reagent to
label 1 μg of antibody. However, for antibody hybridoma
supernatants of unknown concentration we found the use
of 10 μl supernatant and 5 μl of each the Zenon™ labeling
complex and Zenon™ block works best in most cases and
may be determined by titration for each batch of supernatant. Figure 2 shows an example of antibody supernatant
labeling to stain CD11c+ antigen presenting cells.
One option that the Zenon™ protocol provides is to
stop the labeling after the first step (before adding the
blocking reagent) for storage at 4 °C. While our laboratory sometimes stores the Zenon labeled antibody for 1–
2 h in the refrigerator, the manufacturer’s protocol
allows for storage of up to several weeks with the
addition of 2 mM sodium azide (Invitrogen™). The use of
the Zenon™ labeling kits is quick and allows flexibility in
staining because the fluorochrome can easily be changed
by using the isotype-specific Zenon™ kit in a different
color. Multiple Zenon™ labeled antibodies can be used
simultaneously in the same staining panel, and isotype
controls can be labeled in the same manner as the staining antibodies. Each new antibody-Zenon combination
should be titrated to determine the best dilution.
Labeled secondary antibodies and other second step
reagents

For the flow cytometric analysis of cells from veterinary
species fluorochrome-labeled secondary antibodies are
widely used. Monoclonal and polyclonal secondary antibodies are produced in a diverse array of host species and
are commercially available in a broad range of colors. The
use of monoclonal secondary (and primary) antibodies is
preferred as they usually achieve more consistent staining
with less background. Secondary antibodies are employed
to bind primary antibodies (which recognize antigens on
target cells) without cross-recognition of target species

antigens. Therefore, secondary antibodies recognize the
species and isotype of the primary antibody and are
adsorbed to or otherwise unreactive with antigens on cells
of the target species. For example, a monoclonal mouse
IgM antibody that recognizes sheep B cells (clone 2–104)
[44] was visualized with a BV650-conjugated rat antimouse IgM monoclonal antibody (Fig. 2a and d). In the
same staining panel, mouse anti-ovine CD62L clone
DU1–29 was detected with a PE-Cy7-conjugated rat antimouse IgG1 monoclonal antibody (Fig. 2b and d). Thus,
use of secondary antibodies leads to signal amplification
and is versatile, allowing for the selection of less commonly used fluorochromes and easy matching to a variety
of panels.
As a general rule, it is possible to use multiple secondary
antibodies in the same staining panel as long as they
recognize different immunoglobulin classes or IgG subclasses (e.g. anti-mouse IgG and anti-mouse IgM as shown
in Fig. 2, or anti-mouse IgG1, and anti-mouse IgG2a). Even
when using a single secondary antibody, the isotypes of all
antibodies in the staining panel must be considered and the
primary antibody that is targeted should be the only one
recognized by the secondary antibody. However, including
two additional staining steps allows for detection of an unlabeled primary antibody in the presence of additional (labeled) antibodies of the same isotype without crossrecognition by the secondary antibody. The first step includes only the primary antibody, followed by only the
isotype-specific secondary antibody. After a requisite blocking step with excess unlabeled antibody of the isotype of the
target antibody, additional antibodies of the same isotype
can be used in a third staining step. Using this approach our
laboratory visualized CD62L expressing cells (Fig. 2) as well
as natural killer (NK) cells (Fig. 4a and b) with anti-IgG1
secondary antibodies in the presence of other IgG1 staining
antibodies. In Fig. 4, unlabeled EC1.1, a monoclonal mouse
IgG1 that recognizes the ovine natural cytotoxicity receptor
NKp46 [45] was visualized by rat anti-mouse IgG1, clone
A85–1, conjugated to BUV395 (Fig. 4a and b). Following
the secondary labeling, the cells were blocked with nonspecific polyclonal mouse IgG to saturate any free valences
of the secondary antibody, rendering it unable to interfere
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Fig. 3 The principle of Zenon™ antibody labeling. To label mouse monoclonal IgG antibodies, we employed Zenon™ technology. All steps were
performed at room temperature. (a) The unlabeled target monoclonal mouse IgG (purple) is mixed with mouse IgG subclass-specific
fluorochrome-conjugated Fab fragments (green/yellow) from the corresponding Zenon™ kit. The fluorochrome-conjugated Fab fragments bind
the target antibody. (b) Addition of nonspecific polyclonal mouse immunoglobulin (white) blocks excess unbound Fab fragments. (c) The mix of
newly Zenon™-labeled antibodies and blocked excess Fab fragments is added to the cell sample and binds to its respective cell surface antigens.
Antibodies (Zenon-labeled or directly conjugated) to other cell surface molecules can be included in this step. (d) Excess antibody and blocked
Fab fragments are washed away, and (e) the stained cells are ready to be analyzed or fixed

with the other mouse IgG1 antibodies in the staining panel.
Finally, mouse IgG1 antibodies against α4- and β1-integrins
were employed in the staining procedure (Fig. 4a and b).
Isotype control antibodies of the same species, antibody isotype and fluorescent label can be incorporated in the same
manner as the staining antibodies (Fig. 4c).
Biotinylated antibodies also increase the fluorochrome
spectrum and signal in flow cytometry. Streptavidin is
commercially available in many different fluorochromes
and binds biotin on the primary antibody with high affinity. This leads to signal amplification, making it particularly useful for detection of antigens with low density
per cell, and stressing the importance to titrate both the
biotinylated primary antibody and the conjugated streptavidin. Many antibodies are commercially available in
biotinylated format and purified antibodies can be biotinylated using antibody/protein biotinylation kits or
Zenon™ technology (see above).

ligands can be used in flow cytometry. Employing this
method, we have previously analyzed ovine lymphocytes
for expression of costimulatory molecules B7.1/B7.2 and
skin homing marker E-selectin ligand (epitopes that include cutaneous lymphocyte antigen) by evaluating binding of CTLA4-human IgG and mouse E-selectin-human
IgG1 chimeric proteins, respectively [32–34]. Here, we
show an example in which E-selectin binding was
visualized with an APC-conjugated mouse monoclonal
antibody that recognizes the human IgG1 portion of the
E-selectin chimeric protein (Fig. 4d). After gating lymphborne CD4 T cells (as in Fig. 2a), we analyzed their percentage of E-selectin ligand expression (Fig. 4d). Because
E-selectin binding requires calcium, a control staining
was performed in EDTA-containing buffer (Fig. 4d). Alternative controls will depend on the specific ligand used
in an experiment, and examples include staining with irrelevant IgG fusion proteins or blockade of staining with
excess unlabeled ligand.

Labeled receptor ligands

When antibodies for cell surface receptors are unavailable or when ligand binding ability, as opposed to simple
receptor expression is the aim of the study, labeled

Discussion
In this methods paper, we present several approaches to
overcome flow cytometry limitations in the analysis of
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Fig. 4 Secondary antibody staining with multiple same-isotype primary antibodies and cell-surface molecule detection by ligand binding. (a)
Summary of the steps to stain with an isotype-specific secondary antibody when its target isotype antibody is present multiple times in the same
staining panel. (b) Staining of NKp46 with an isotype-specific secondary antibody (anti-mouse IgG1) in the presence of anti α4- and β1-integrin
antibodies, which are of the same isotype as the anti NKp46 antibody. Peripheral blood mononuclear cells were pre-gated on single live
lymphocytes as in Fig. 2a and CD3+ T cells and CD3−NKp46+ NK cells analyzed for expression of α4- and β1-integrins. (c) Corresponding isotype
control staining for α4- and β1-integrins. (d) E-selectin ligand expression on CD4+ T cells from afferent lymph of adult sheep was determined by
flow cytometry using an E-selectin-human IgG fusion protein. Cells were pre-gated as in Fig. 2a. As a negative control, staining was performed in
buffer containing EDTA. (b-d) One representative of five individually analyzed sheep is shown. Abbreviations: αm, anti-mouse; APC,
allophycocyanin; BUV, Brilliant ultra violet; FITC, fluorescein isothiocyanate; PE, R-phycoerythrin

veterinary species. During our studies we faced several
technical issues. For example, certain antibody clones
were not sufficiently labeled by direct covalent labeling
kits. This is an old problem and known causes of labeling
resistance include: buffer components react with the dye,
suboptimal pH, or reactive amine groups lie within the

antigen-binding site of the antibody [46]. Zenon antibodies can be a solution for labeling monoclonal IgG antibodies that do not label well with labeling kits. For
example, our ovine CD4 monoclonal antibody (44.38) did
not yield satisfying staining quality when conjugated with
the Invitrogen Pacific Blue antibody labeling kit. However,
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using the Zenon technology yielded superior results. Another common difficulty is the conjugation of IgM antibodies because most labeling kits raise pH and denature
the pentameric structure of IgM [47]. Some manufacturers, such as Thermo Fisher Scientific, offer specific protocols optimized for IgM labeling. In the case of the
(mouse IgG1) anti-NKp46 clone, neither covalent conjugation nor Zenon™ technology were effective methods for
labeling, and we had to employ the staining method outlined in Fig. 4a. Unfortunately, not all commercial antibody suppliers have consistent quality controls in place
and we have occasionally seen commercially labeled antibodies that are unreliable. We also found that in one case
the Zenon™ mix interfered with the staining of a different
antibody in the same staining panel. Specifically, the antiovine B cell antibody (2–104) is a mouse IgM and its detection by an anti-mouse IgM secondary antibody was
blunted. An ELISA revealed that the Zenon™ blocking reagent that is included in the kits contained both mouse
IgG and mouse IgM, and the latter was competing with
our mouse IgM primary antibody for binding by the secondary anti-mouse IgM antibody. We solved the issue by
using purified IgG for blocking rather than the Zenon™ kit
blocking component.
Certain tandem dyes are sensitive to degradation, leading to a weaker signal and detection in other fluorochrome channels. For example, PE-tandem dyes are
susceptible to degradation by handling, storage, and light
[48, 49]. We also found that the tandem dye PE-Cy7, is
sensitive to extended fixation with PFA, which can degrade the fluorophore and lead to artifactual strong signals in the PE channel. We found that the following
precautions prevent tandem conjugate degradation:
staining at 4 °C in the dark, careful and extensive washing after fixation (i.e. twice with sufficient buffer volume), and storage at 4 °C in the dark for no longer than
24 h. Another potential issue, which we have not encountered in our studies, is the interference of Brilliant
Violet and other ultra-bright antibodies with each other
when used in the same panel. Such issues can be addressed by using specialized staining buffers. BD Bioscience, for example, offers a specific buffer for staining
with Brilliant™ dyes [50].
While we present several simple approaches to broaden
the number of flow cytometric parameters per cells, additional approaches exist that we have not utilized so far.
For example, PrimeFlow™ (Invitrogen™) or Branched DNA
method is a technique to detect cell-expressed RNA by
flow cytometry [51], and custom antibody production or
customized antibody labeling are also available.

Conclusion
Here, we presented multiple relatively simple and timetested approaches that broaden the fluorochrome
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spectrum for flow cytometric analysis of cells from veterinary relevant species. These approaches can enhance
the quality and quantity of information obtained from
each cell sample. Therefore, the use of multiparameter
analysis in flow cytometry can give critical insight into
veterinary and other less commonly analyzed species,
can help obtain information from rare cell samples, better define subpopulation of cells, and also potentially reduce the required number of animals used in a study.

Methods
Animals and lymphatic cannulation

Eight–eighteen months old female or wether Dorset or
Dorset-cross sheep with negative Q-fever serology were
purchased from Archer Farms, Inc. and conventionally
housed in standard pens, under a 12-h-light/dark cycle,
in groups and singly when entering experiments. Hay
and water were provided ad libitum, and standard pellet
feed for ruminants (Labiana) were fed twice per day.
Sheep were 40–65 kg of weight when entering experiments Lymphadenectomy to remove the subiliac (prefemoral) lymph nodes was performed as previously
described [52]. Six–eight weeks after lymphadenectomy,
pseudoafferent lymph vessels were cannulated with
heparin-primed 3 or 3.5 French polyurethane catheters
(Access Technologies) in a surgical procedure as described [52]. Pre-procedural sedation was induced with
Tilzolan (tiletamine and zolazepam; Dechra) at 4–6 mg/
kg into muscles of the hind or front leg; anesthesia was
induced with propofol i.v. at 2–8 mg/kg (PropoFlo 28,
Zoetis) and/or sevoflurane (Patterson Veterinary) per inhalation at 2–3% in oxygen via mask, and anesthesia was
maintained at a surgical plane with 2–3% isoflurane (Isothesia, Covetrus) in oxygen, administered via an endotracheal tube. All surgical procedures were performed
under aseptic conditions in a dedicated surgical suite.
Postoperative analgesia was provided using buprenorphine (Par Pharmaceuticals) at 0.01–0.05 mg/kg every
4–12 h s.c. in the neck, and/or flunixin meglumine (Flunixin Injection, Norbrook) at 1 mg/kg every 8–24 h i.m.
in the leg. Additional doses of analgesics were given if
animals showed signs of pain or distress, which were
assessed at least three times per day for 3 days, and at
least every 12–24 h thereafter for a week. Afferent lymph
was collected into sterile bottles containing 100 μL of 10,
000 U/mL Heparin (Hospira, Inc.). Collection bottles
were changed every 4–12 h. After conclusion of experiments, the animals were euthanized while under
anesthesia by i.v. injection with pentobarbital and phenytoin (SomnaSol, Covetrus) at 97.5–195 mg/kg and 12.5–
25/kg, respectively. Death was confirmed by auscultation
for cardiac arrest. The method of euthanasia is consistent with the recommendations by the Panel of Euthanasia of the American Veterinary Medical Association.
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Cell isolation and blood collection

Blood was collected from the jugular vein with a syringe
containing heparin. Mononuclear cells were isolated
using density gradient centrifugation with Histopaque®1083 (Sigma-Aldrich). Blood was diluted at a one to one
ratio with elution media (58.4 mM sucrose (Sigma-Aldrich), 10 ml 5 mM EDTA (Invitrogen), 100 mL 10x PBS
(Gibco), 900 mL Milli-Q Water) at room temperature
and carefully layered on top of the Histopague in a conical tube. The layered blood is centrifuged at 9000 RCF
for 30 min. Lymphocytes are collected by harvesting the
buffy coat. Blood and lymph-borne cells were washed
with wash media (RPMI 1640 medium with GlutaMAX™
(Gibco®), 0.2% BSA (Sigma-Aldrich), and 25 mM HEPES
(Gibco®)), and, when necessary, red blood cells were
lysed using red blood cell lysing buffer (155 mM ammonium chloride (Sigma-Aldrich), 10 mM sodium bicarbonate (Sigma-Aldrich), and 0.1 mM EDTA (Gibco)).
Isolated cells were resuspended in wash media, counted
by hemocytometer, and kept on ice until staining.
Flow cytometry

Mouse monoclonal anti-ovine antibodies recognizing the
following ovine antigens were used in the study: CD4
(clone 44.38; BioRad), CD8 (38.65; BioRad), γδ TCR (86D;
Washington State University Monoclonal Antibody Center), CD62L (DU1–29; Washington State University
Monoclonal Antibody Center), and NKp46 (EC1.1; Timothy Connelly and Lindert Benedictus, The Roslin Institute); CD11c (17–196) and pan-B cell marker (2–104)
were kindly provided as hybridoma supernatant or purified antibody by Alan Young (South Dakota State University) and Isabelle Schwartz-Cornil (Institut national de la
recherche agronomique). The following mouse monoclonal antibodies, cross-reactive with sheep antigens [39, 40],
were used: α4-integrin (HP2/1; Novus Biologicals), β1integrin (TS2/16; eBioscience), and CD21 (CC21; BioRad).
The following secondary antibodies were employed in our
study: rat anti-mouse IgG1 BUV395 (A85–1, BD Biosciences), rat anti-mouse IgG1 PE-Cy7 (RMG1–1; Biolegend), rat anti-mouse IgM (II/41, BD Biosciences), and
mouse anti-human IgG1 APC (97,924; R&D Systems).
Streptavidin-conjugated PerCP-Cy5.5 (BD Bioscience) was
used as a secondary or tertiary step reagent. Unlabeled
antibodies were labeled with Zenon™ kits or Molecular
Probes (Invitrogen™) antibody/protein conjugation kits, as
indicated in each Figure, following the manufacturer’s instructions (Invitrogen™, ThermoFisher Scientific). The
Zenon™ labeling blocking step was performed with purified whole mouse IgG (Jackson ImmunoResearch).
All staining steps were performed in a total volume of
100 μl on ice. Cells were washed with staining buffer
(Dulbecco’s phosphate-buffered saline (DPBS; Corning)
and 0.2% tissue-culture grade bovine serum albumin
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(BSA; Sigma-Aldrich)) and spun down at 500 RCF. 2 ×
106 cells were stained per 1.2 mL microtiter tube (Fisher
Scientific). To block nonspecific binding, each tube of
cells was resuspended, and subsequently incubated for
10 min, in 10 μl of staining buffer containing 1 μg sheep
IgG (Jackson ImmunoResearch) and/or 1 μg mouse IgG
(Jackson ImmunoResearch), as well as 0.1 μl of the
LIVE/DEAD™ Fixable Aqua Dead Cell Stain Kit (Invitrogen™). The blocking step was performed at the beginning
of the staining process or after staining with a secondary
antibody before addition of antibodies of the same isotype as the primary antibody (Fig. 2 and Fig. 4 a and b).
After blocking, antibodies to cell surface antigens were
added and cells incubated for 15 min, and subsequently
washed with staining buffer. Cells were then fixed by
resuspending and incubating for 15 min in 2% paraformaldehyde (Sigma Aldrich), followed by washing with
staining buffer. After fixation, ovine CD3 staining was
performed in staining buffer containing 0.5% saponin
(from Quillaja bark, molecular biology grade; Sigma Aldrich). Binding to a mouse E-selectin-human IgG1
chimeric protein (R&D Systems) was tested in DPBS
containing calcium and magnesium (Corning), and visualized by an APC-conjugated mouse anti-human IgG1
antibody (clone 97,924; R&D Systems). The control was
stained in the same manner using DPBS without calcium
and magnesium under the addition of 30 mM ethylenediamine tetraacetic acid (EDTA; Invitrogen™). Data was
acquired using the BD LSR Fortessa™ (BD Biosciences)
and analyzed with FlowJo software (Tree Star). A single
cell gate was set for each cell sample using FSC-Area
and FSC-Height as depicted in Fig. 2a. Dead cells were
excluded from analysis by gating on LIVE/DEAD™ Fixable Aqualow events, and lymphocyte and/or granulocyte
gates were drawn based on SSC-Area and FSC-Area
(Fig. 2a). A minimum of 100,000 lymphocytes were recorded per tube.
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